A vaccine for respiratory syncytial virus (RSV) is now available for older Canadians, but experts worry that cost of the vaccine could be a barrier to seniors and could lead to preventable hospitalizations — and potentially, death.
Health
Cost of RSV vaccine a barrier to older Canadians amid respiratory season, experts warn
More Videos
-
Health Matters: ‘Suicide pod’ creator rejects claim that 1st user was strangled
-
Genetics insights and AI-driven discoveries: Hope for the future of cancer
-
Health Matters: New Brunswick measles outbreak rises to 44 cases
-
Health Matters: WHO approves first mpox vaccine for kids
-
Stretch, strengthen, and Save with band workouts
-
Organic carrots recalled over E. coli outbreak
You are viewing an Accelerated Mobile Webpage.
View Original Article